• Explore /
  • Poster
  • / Correlation of <em>CDKN2A </em>genomic alterations with tumor response to palbociclib given before chemoradiation therapy (CRT) to patients with human papillomavirus (HPV)-negative, locally advanced head and neck squamous-cell carcinoma (LA-HNSCC): A single-arm, phase 2 trial.

Correlation of CDKN2A genomic alterations with tumor response to palbociclib given before chemoradiation therapy (CRT) to patients with human papillomavirus (HPV)-negative, locally advanced head and neck squamous-cell carcinoma (LA-HNSCC): A single-arm, phase 2 trial.

Abstract Poster

Authors

null

Peter John Oppelt

Washington University School of Medicine, St. Louis, MO

Peter John Oppelt , Jessica C. Ley , Randal C Paniello , Sidharth Puram , Ryan Jackson , Patrik Pipkorn , Jason Rich , Hiram Alberto Gay , Jingxia Liu , Jared Cohen , Wade Thorstad , Douglas Adkins

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Head and Neck Cancer

Track

Head and Neck Cancer

Sub Track

Local-Regional Disease

Clinical Trial Registration Number

NCT03389477

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr 6015)

DOI

10.1200/JCO.2023.41.16_suppl.6015

Abstract #

6015

Poster Bd #

7

Abstract Disclosures

Similar Posters

First Author: Jerome Fayette

First Author: Bhumsuk Keam

First Author: Jessica C. Ley

First Author: Douglas Adkins